- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Lexicon Pharmaceuticals Inc+ Add to Watchlist
LXRX:US1.7900 USD 0.0100 0.56%
As of 20:10:00 ET on 03/07/2014.
Company Profile for Lexicon Pharmaceuticals Inc (LXRX)
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company researches treatments for diabetes and obesity, cardiovascular disease, psychiatric and neurological disorders, cancer, immune system disorders, and ophthalmic disease.
Lexicon Pharmaceuticals Inc
Key Executives for Lexicon Pharmaceuticals Inc (LXRX)
|Arthur T SandsPresident/CEO/Co-Founder||Jeffrey L WadeExec VP:Corporate Dev/CFO|
|Pablo LapuertaExec VP:Clinical Dev||Brian P ZambrowiczExec VP/Chief Scientific Ofcr|
|Alan J MainExec VP:Pharmaceutical Research||James F TessmerVP:Finance & Accounting|